Instituto Universitario de Tecnologías Biomédicas
Ikerketa institutua
University Hospital Heidelberg
Heidelberg, AlemaniaUniversity Hospital Heidelberg-ko ikertzaileekin lankidetzan egindako argitalpenak (12)
2024
-
Multicenter Long-Term Real World Data on Treatment With Lumasiran in Patients With Primary Hyperoxaluria Type 1
Kidney International Reports, Vol. 9, Núm. 1, pp. 114-133
2023
-
PHYOX2: a pivotal randomized study of nedosiran in primary hyperoxaluria type 1 or 2
Kidney International, Vol. 103, Núm. 1, pp. 207-217
2018
2017
-
A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction
Journal of Hepatology, Vol. 67, Núm. 4, pp. 669-679
2016
2014
-
Doporuečené postupy European Renal Best Practice (ERBP) pro posuzování dárců a příjemců pro transplantaci ledviny a pro perioperační péči
Aktuality v Nefrologii, Vol. 20, Núm. 2, pp. 78-85
-
Guías Europeas sobre manejo y evaluación de receptores y donantes renales
Nefrologia, Vol. 34, Núm. 3, pp. 293-301
2013
-
Guideline
Nephrology Dialysis Transplantation, Vol. 28, Núm. SUPPL.2
-
Novel findings in patients with primary hyperoxaluria type III and implications for advanced molecular testing strategies
European Journal of Human Genetics, Vol. 21, Núm. 2, pp. 162-172
2012
-
Guidelines for the use and interpretation of assays for monitoring autophagy
Autophagy, Vol. 8, Núm. 4, pp. 445-544
-
Liver cell transplantation in severe infantile oxalosisa potential bridging procedure to orthotopic liver transplantation?
Nephrology Dialysis Transplantation, Vol. 27, Núm. 7, pp. 2984-2989